Fujifilm Presents Next Generation of Synapse® Cardiovascular at the ACC Scientific Session & Expo

STAMFORD, Conn.--(BUSINESS WIRE)--(Booth # 21076) – FUJIFILM Medical Systems U.S.A., Inc., will demonstrate the next generation of echocardiography, cardiac cath image management and structured reporting with the latest version of Synapse Cardiovascular at the American College of Cardiology (ACC) 65th Annual Scientific Session & Expo held April 2 – 4, 2016 at McCormick Place in Chicago, IL. The latest version provides a streamlined and efficient clinical experience for cardiologists and sonographers with new module enhancements.

“Developed with direction from cardiologists, Synapse Cardiovascular offers capabilities and tools that help streamline workflow, image review, and reporting for a variety of cardiac areas,” said Johann Fernando, chief operating officer, FUJIFILM Medical Systems U.S.A., Inc.

Synapse Cardiovascular helps cardiologists in a variety of clinical areas efficiently and confidently interpret images and compose structured reports with a streamlined workflow. Latest enhancements include Pediatric Echocardiography modules and a redesigned image measurement package. The system also has powerful capabilities designed specifically for echocardiography, cardiac catheterization and invasive peripheral vascular, nuclear cardiology, vascular ultrasound, ECG management, CT, and Cardiac MRI workflows.

To learn more about Synapse Cardiovascular at ACC, please visit here. For more information about Fujifilm, please visit: www.fujifilmhealthcare.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced endoscopes to the medical market. The TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit http://www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.

 

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2015, the company had global revenues of $20.8 billion, at an exchange rate of 120 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."